Climb Bio Inc Financial Flexibility Index
Climb Bio Inc financial flexibility index. Climb Bio Inc (CLYM) has a Financial Flexibility Index of -1.52x as of June 2026. Free cash flow of $-10.29 Million (operating CF $-10.55 Million minus capex $260.00K) represents -2% of total liabilities ($6.75 Million). See Climb Bio Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Climb Bio Inc (2019–2025)
Financial flexibility index of Climb Bio Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Climb Bio Inc across 7 annual periods. Explore CLYM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Climb Bio Inc Financial Flexibility Index by Year (2019–2025)
Climb Bio Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Climb Bio Inc. For the full cash flow conversion analysis, see CLYM cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.45x | $-54.17 Million | $-54.36 Million | $7.27 Million | ▼ -154.1% |
| 2024 | -2.93x | $-15.56 Million | $-15.56 Million | $5.31 Million | ▲ +59.1% |
| 2023 | -7.18x | $-20.60 Million | $-20.60 Million | $2.87 Million | ▼ -20.6% |
| 2022 | -5.95x | $-37.37 Million | $-37.37 Million | $6.28 Million | ▲ +0.3% |
| 2021 | -5.97x | $-36.07 Million | $-36.07 Million | $6.04 Million | ▼ -29.8% |
| 2020 | -4.60x | $-14.10 Million | $-14.10 Million | $3.06 Million | ▲ +28.0% |
| 2019 | -6.40x | $-5.01 Million | $-5.01 Million | $783.00K | — |